The effect of calcium dobesilate combined with hypoglycemic drugs in the treatment of cataract NPDR and its effect on fundus microcirculation and blood ICAM-1, MCP-1 and MIF levels
Abstract
Purpose: To explore the effect of calcium dobesilate combined with hypoglycemic drugs in the treatment of cataract complicated with non-proliferative diabetic retinopathy (NPDR) and its effects on fundus microcirculation, intercellular adhesion molecule 1 (ICAM-1), monocyte chemoattractant protein 1 (MCP-1), and macrophage migration inhibitory factor (MIF).
Methods: From March 2019 to January 2021, A total of 114 patients with cataract and NPDR were included, and the patients were assigned into the control and the observation groups by random number table method, with 57 cases/group. The control was given hypoglycemic drugs, and the observation was given calcium dobesilate combined therapy. The therapeutic efficacy, blood glucose and blood lipid levels, fluorescein fundus angiography results, fundus microcirculation indexes, retinal neovascularization-related factors, and ICAM-1, MCP-1, and MIF levels before and after treatment were compared between the two groups.
Results: The total effective rate of treatment in the observation was higher vs. the control (P < 0.05); Fasting blood glucose (FBG), 2 h postprandial blood glucose (2hPG), glycosylated hemoglobin (HbA1C), triglyceride (TG), total cholesterol (TC) and low density lipoprotein (LDL) in the observation after treatment were reduced vs. the control (P < 0.05); The number of micro-hemangiomas in the observation after treatment was less vs. the control, and the area of hemorrhage, the area of exudation and the thickness of the yellow plate were smaller vs. the control (P < 0.05); The resistance index (RI) value of the observation after treatment was lower than the control, and the end-diastolic blood flow velocity (EDV) and the peak systolic blood flow velocity (PSV) of the observation were higher vs. the control (P < 0.05). ICAM-1, MCP-1, MIF, vascular endothelial growth factor (VEGF) and insulin-like growth factor-1 (IGF-1) in the observation after treatment were reduced vs. the control, but pigment epithelium-derived factor (PEDF) were higher vs. the control (P < 0.05); one case of gastrointestinal reaction took place in the observation, but no adverse reaction occurred in the control, and no clear difference exhibited in the incidence of adverse reactions between the two groups (P > 0.05).
Conclusion: Calcium dobesilate combined with hypoglycemic drugs has good clinical efficacy in the treatment of cataract complicated with NPDR, which can effectively reduce the level of blood glucose and blood lipids, reduce inflammation, and mitigate the microcirculation of branch retinal vein occlusion lesions.
References
[2] Yanpeng Chen, Zhenzhen Tong, Tingting Zhao, et al. Changes of pupil diameter and ocular hemodynamics in patients with NPDR and cataract who received mydriasis in the early stage after cataract surgery [J]. Shandong Medicine, 2020, 60(30) :31-34.
[3]Shen ZJ, Yang XF, Xu J, et al. Association of choroidal thickness with early stages of diabetic retinopathy in type 2 diabetes[J]. Int J Ophthalmol, 2017, 10(4):613-618.
[4] Xuemei Wu, Shuhuan Yang, Zhihua Han, et al. Effect of calcium dobesilate on fundus microcirculation in patients with diabetic retinopathy complicated with cataract [J]. International Journal of Ophthalmology, 2018, 18(5):873-877.
[5]Ashraf H, Lotfi M, Akbari M, et al. Effect of calcium dobesilate on retrobulbar blood flow and choroidal thickness in patients with non-proliferative diabetic retinopathy[J]. Int Ophthalmol, 2021, 41(10):3479-3486.
[6] Lingbiao Sun. Guidelines for the prevention and treatment of cataract [M]. Beijing: People's Health Publishing House, 1998:5-6.
[7] Fundus Diseases Group, Chinese Academy of Ophthalmology. Guidelines for Clinical Diagnosis and Treatment of Diabetic Retinopathy in China (2014) [J]. Chinese Journal of Ophthalmology, 2014, 50(11):851-865.
[8] Yaqin Song, Jing Wu, Lu Yang, et al. Study on the efficacy and safety of Zhixue Sanyu Mingmu Decoction combined with calcium dobesilate in the treatment of choroid stasis type diabetic retinopathy [J]. Chinese Journal of Traditional Chinese Medicine, 2020, 38(10):190-193.
[9] Wei Yu, Bosong Lin, Shufeng Ma, et al. Efficacy of calcium dobesilate combined with Fufangxueshuantong capsule in the treatment of early diabetic retinopathy and its effect on serum IGF-1 and VEGF levels[J]. Chinese Journal of Gerontology, 2017, 37(21):5311-5313.
[10]Mukhtar A, Khan MS, Junejo M, et al. Effect of pan retinal photocoagulation on central macular thickness and visual acuity in proliferative diabetic retinopathy[J]. Pak J Med Sci, 2016, 32(1):221-224.
[11]Guo X, Zhao F, Yin Y, et al. Calcium dobesilate: A drug treatment for diabetic retinopathy can negatively interfere with the measurement of glycated albumin using the enzymatic method[J]. Clin Chim Acta, 2018, 483(8):1-5.
[12] Liqin Ling, Yun Zhang. Clinical observation on the treatment of non-proliferative diabetic retinopathy with the method of nourishing qi and tonifying kidney and promoting blood circulation combined with calcium dobesilate [J]. Liaoning Journal of Traditional Chinese Medicine, 2018, 45(12):2553-2555.
[13] Pan Chen, Xue Bai. Clinical observation of benazepril combined with calcium dobesilate assisted insulin in the treatment of early diabetic nephropathy in the elderly [J]. China Pharmacy, 2017, 28(3):347-350.
[14]Zhou Y, Qi C, Li S, et al. Investigation of the Mechanism Underlying Calcium Dobesilate-Mediated Improvement of Endothelial Dysfunction and Inflammation Caused by High Glucose[J]. Mediators Inflamm, 2019, 21(10):9893682.
[15]Ye H, Yu M, Lu L, et al. Electroretinogram evaluation for the treatment of proliferative diabetic retinopathy by short-pulse pattern scanning laser panretinal photocoagulation (vol 33, pg 1095, 2018)[J]. Lasers Med Sci, 2018, 33(5):1095-1102.
[16]Yalvac E, Demiroglu M, Gursel S, et al. Calcium dobesilate versus micronised purified flavonoid fraction of diosmin in the treatment of chronic venous disease: A randomized prospective study[J]. Acta Medica Mediterr, 2018, 34(3):657-661.
[17]Wang Y, Zuo B, Wang N, et al. Calcium dobesilate mediates renal interstitial fibrosis and delay renal peritubular capillary loss through Sirt1/p53 signaling pathway[J]. Biomed Pharmacother, 2020, 132(11):110798.
[18] Liqin Ling, Yun Zhang. Clinical observation of Yiqi, Bushen and Huoxue combined with calcium dobesilate in the treatment of non-proliferative diabetic retinopathy [J]. Liaoning Journal of Traditional Chinese Medicine, 2018, 45(12):95-97.
[19] Nan Zhang, Jiajun Xu, Jingru Zhao, et al. Efficacy of Shiqing Decoction on patients with stasis-heat blocking collateral type cataract complicated with non-proliferative diabetic retinopathy [J]. Zhonghua Journal of Traditional Chinese Medicine, 2018, 33(1):386- 389.
[20]Han K, Liu C, Shi X, et al. Effects of alprostadil combined with calcium dobesilate in patients with diabetic peripheral neuropathy.[J]. Neuro Endocrinol Lett, 2018, 39(2):143-147.
[21] Jiayao Xu, Wenguang Xian, Lina Liu. The relationship between serum VEGF and ICAM-1 levels and microvascular damage in patients with diabetic retinopathy [J]. Chinese Journal of Gerontology, 2017, 37(8):2000-2002.
[22] Xiaozhen Ye, Bin Lu, Li Peng, et al. A case of agranulocytosis induced by calcium dobesilate in the treatment of diabetic retinopathy [J]. Chinese Journal of Endocrinology and Metabolism, 2017, 33(2):145-146.
[23] Jue Wang, Wei Du, Yan Li. The efficacy of calcium dobesilate combined with Fufang Xueshuantong capsule in the treatment of senile diabetic retinopathy and its effect on hemorheology [J]. Chinese Journal of Gerontology, 2020, 40(8 ): 1603-1606.
[24] Li Li. Effects of laser photocoagulation combined with calcium dobesilate and Xueshuantong on microcirculation and inflammatory factors in diabetic retinopathy [J]. Applied Laser, 2019, 39(3):530-534.
[25] Ying Xing, Likai Xie, Siyu Zhong. Calcium dobesilate combined with irbesartan in reversing early diabetic nephropathy [J]. Chinese Journal of Gerontology, 2020, 40(19):4079-4081.
[26] Zhaozhao Huang, Jun Qiu. Effects of calcium dobesilate and triamcinolone acetonide treatment on serum VEGF and ICAM-1 in DME patients [J]. Genomics and Applied Biology, 2019, 38(11):5320- 5325.
Copyright (c) 2023 Zhao Zhang, XiaoMan Wang, YiQing Ge, Xia Wu, YinChao Ma
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.